Diltiazem hydrochloride: New technologies and evolution of diltiazem (Q94556574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json

15 May 2020

title

Diltiazem hydrochloride: New technologies and evolution of diltiazem (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json

15 May 2020

Stephen P. Glasser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json

15 May 2020

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json

15 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json

15 May 2020

issue

Suppl 4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json

15 May 2020

page(s)

16-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json

Risk factors in hypertension.

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

The use of combination drug therapy in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

High blood pressure and calcium antagonism

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Clinical pharmacokinetics of calcium antagonists. An update

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Optimizing delivery systems to tailor pharmacotherapy to cardiovascular circadian events

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Circadian variation of blood-pressure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Cyclic and circadian variations in cardiovascular events

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Circadian variation in the frequency of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Circadian variation in the frequency of onset of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

The influence of time of administration on the pharmacokinetics of a once-a-day diltiazem formulation: morning against bedtime

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Anomalies in the dosing of diltiazem

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Circadian variation of transient myocardial ischemia in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Prognostic significance of blood pressure measured on rising

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960261605

7 January 2021

Identifiers

DOI

10.1002/CLC.4960261605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654580&resulttype=core&format=json